Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha

被引：23
|
作者：
Verma, Dushyant [1 ]
Kantarjian, Hagop [1 ]
Jain, Nitin [1 ]
Cortes, Jorge [1 ]
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
LEUKEMIA & LYMPHOMA | 2008年 / 49卷 / 07期
关键词：
D O I：
10.1080/10428190802043903
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1399 / 1402
页数：4
相关论文
共 50 条
  • [31] Discontinuation of Imatinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Complete Molecular Response: Update Results of the STIM Study
    Mahon, Francois-Xavier
    Rea, Delphine
    Guilhot, Joelle
    Guilhot, Francois
    Huguet, Francoise
    Nicolini, Franck E.
    Legros, Laurence
    Charbonnier, Aude
    Guerci, Agnes
    Varet, Bruno R.
    Etienne, Gabriel
    Reiffeis, Josy
    Rousselot, Philippe
    BLOOD, 2011, 118 (21) : 277 - 277
  • [32] Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete genetic response after alpha interferon treatment
    Casado, LF
    Pico, M
    Gomez, C
    Ferro, MT
    FernandezRanada, JM
    Steegmann, JL
    MEDICINA CLINICA, 1997, 109 (07): : 251 - 255
  • [33] Immunomodulatory influence by interferon alpha and imatinib mesylate in chronic myeloid leukemia
    Yokoyama, Kazuaki
    Nagamura-Inoue, Tokiko
    Nakayama, Shin
    Ishige, Ikuo
    Ohno, Nobuhiro
    Takahashi, Satoshi
    Uchimaru, Kaoru
    Iseki, Toru
    Tojo, Arinobu
    BLOOD, 2007, 110 (11) : 205B - 205B
  • [34] Kinetics of molecular response to imatinib in chronic myeloid leukemia patients may predict persistent polymerase chain reaction negativity after imatinib discontinuation
    Rege-Cambrin, Giovanna
    Ulisciani, Stefano
    Mattioli, Giovanna
    Fava, Carmen
    Giugliano, Emilia
    Brunetto, Vanessa
    Gottardi, Enrico
    Fava, Milena
    Saglio, Giusppe
    BLOOD, 2007, 110 (11) : 581A - 582A
  • [35] Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation
    Fava, Carmen
    Ulisciani, Stefano
    Giugliano, Emilia
    Brunetto, Vanessa
    Gottardi, Enrico
    Giaretto, Lorena
    Saglio, Giuseppe
    Rege-Cambrin, Giovanna
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (06): : E42 - E42
  • [36] Imatinib mesylate therapy in late Ph plus chronic myeloid leukemia patients in stable complete cytogenetic response after interferon-alpha results in a very high complete molecular response rate.
    Alimena, Giuliana
    Breccia, Massimo
    Luciano, Luigia
    Quarantelli, Fabrizio
    Diverio, Damiela
    Izzo, Barbara
    De Angelis, Biagio
    Mancini, Marco
    Latagliata, Roberto
    Carmosino, Ida
    Nanni, Mauro
    Rotoli, Bruno
    Mandelli, Franco
    Pane, Fabrizio
    BLOOD, 2006, 108 (11) : 612A - 612A
  • [37] Therapy-Free Remission after Interferon Alfa Maintenance with Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia
    Usuki, Kensuke
    Suzuki, Kenshi
    Kimura, Shinya
    Tojo, Arinobu
    BLOOD, 2014, 124 (21)
  • [38] Delayed acute pancreatitis induced by nilotinib in a patient with chronic myeloid leukemia attaining sustained complete molecular response
    Wang, Shifang
    Desikan, Sai Prasad
    Jeffrey, Jay
    McClain III, Charles
    Desikan, Raman
    EJHAEM, 2020, 1 (01): : 309 - 311
  • [39] Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response
    Yhim, Ho-Young
    Lee, Na-Ri
    Song, Eun-Kee
    Yim, Chang-Yeol
    Jeon, So Yeon
    Shin, Seunghwan
    Kim, Jeong-A
    Kim, Hee Sun
    Cho, Eun Hae
    Kwak, Jae-Yong
    LEUKEMIA RESEARCH, 2012, 36 (06) : 689 - 693
  • [40] MOLECULAR RELAPSE IN CHRONIC MYELOID LEUKEMIA PATIENTS AFTER IMATINIB DISCONTINUATION: DOES IT ALWAYS NEED THERAPY?
    Rege-Cambrin, G.
    Fava, C.
    Ulisciani, S.
    Giugliano, E.
    Gottardi, E.
    Fava, M.
    Giaretto, L.
    Saglio, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 576 - 577
12345